Literature DB >> 19635589

Flrt2 and Flrt3 have overlapping and non-overlapping expression during craniofacial development.

S-G Gong1, S Mai, K Chung, K Wei.   

Abstract

Craniofacial morphogenesis is a complex multi-step process that involves numerous biological processes to coordinate the growth, proliferation, migration, and subsequent differentiation of the cranial neural crest cells. Members of the Fibronectin Leucine-Rich Transmembrane (Flrt) gene family have been previously reported to be widely expressed in the developing embryo. We mapped the expression of Flrt2 and Flrt3 at critical stages of craniofacial development and found that, during early craniofacial development, Flrt2 was highly expressed initially in the cranial neural crest cells and Flrt3 in the midbrain. Later both genes were expressed in the developing pharyngeal region. Flrt2 expression predominated in the neural crest-derived mesenchyme in the medial aspect of the developing frontonasal region in close relationships with the expression of Fgfr2, Shh, and Msx1, three genes shown previously to play critical roles in craniofacial development. Flrt2 was also present in the vomero-nasal organ, mandibular primodia, and the posterior aspects of the unfused and fused secondary palatal shelves. Flrt3, however, had a more restrictive expression, being present in the mesenchyme underlying the ectoderm of the medial nasal process and in the mandibular primordium and in regions undergoing outgrowth, in a pattern that overlapped with Bmp4 expression. Both Flrt2 and Flrt3 were later found to be present at sites of epithelial-mesenchymal interactions such as the developing tooth buds, hair follicles, and eye. Together the data suggested important roles for Flrt2 and Flrt3 in mediating events such as NCC migration, chondrogenesis and epithelial-mesenchymal interactions during craniofacial development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635589     DOI: 10.1016/j.gep.2009.07.009

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  6 in total

1.  Interstitial deletion 14q31.1q31.3 transmitted from a mother to her daughter, both with features of hemifacial microsomia.

Authors:  S Gimelli; C Cuoco; P Ronchetto; G Gimelli; E Tassano
Journal:  J Appl Genet       Date:  2013-05-05       Impact factor: 3.240

2.  Genetic and genomic characterization of vulva size traits in Yorkshire and Landrace gilts.

Authors:  Flor-Anita Corredor; Leticia P Sanglard; Richard J Leach; Jason W Ross; Aileen F Keating; Nick V L Serão
Journal:  BMC Genet       Date:  2020-03-12       Impact factor: 2.797

3.  Genome-wide identification of Chiari malformation type I associated candidate genes and chromosomal variations.

Authors:  Timuçin AvŞar; Şeyma ÇaliŞ; Baran Yilmaz; Gülden Demİrcİ OtluoĞlu; Can Holyavkİn; Türker KiliÇ
Journal:  Turk J Biol       Date:  2020-12-14

4.  A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.

Authors:  Tsuyoshi Shirai; Hiroshi Fujii; Masao Ono; Kyohei Nakamura; Ryu Watanabe; Yumi Tajima; Naruhiko Takasawa; Tomonori Ishii; Hideo Harigae
Journal:  Arthritis Res Ther       Date:  2012-07-02       Impact factor: 5.156

5.  An extracellular biochemical screen reveals that FLRTs and Unc5s mediate neuronal subtype recognition in the retina.

Authors:  Jasper J Visser; Yolanda Cheng; Steven C Perry; Andrew Benjamin Chastain; Bayan Parsa; Shatha S Masri; Thomas A Ray; Jeremy N Kay; Woj M Wojtowicz
Journal:  Elife       Date:  2015-12-02       Impact factor: 8.140

6.  Enhanced synaptic plasticity and spatial memory in female but not male FLRT2-haplodeficient mice.

Authors:  Ana Cicvaric; Jiaye Yang; Tanja Bulat; Alice Zambon; Manuel Dominguez-Rodriguez; Rebekka Kühn; Michael G Sadowicz; Anjana Siwert; Joaquim Egea; Daniela D Pollak; Thomas Moeslinger; Francisco J Monje
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.